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Abstract
DNp63a, a proto-oncogene, is up-regulated in non-melanoma skin cancers and directly regulates the expression of both
Vitamin D receptor (VDR) and phosphatase and tensin homologue deleted on chromosome ten (PTEN). Since DNp63a has
been shown to inhibit cell invasion via regulation of VDR, we wanted to determine whether dietary Vitamin D3 protected
against UVB induced tumor formation in SKH-1 mice, a model for squamous cell carcinoma development. We examined
whether there was a correlation between dietary Vitamin D3 and DNp63a, VDR or PTEN expression in vivo in SKH-1 mice
chronically exposed to UVB radiation and fed chow containing increasing concentrations of dietary Vitamin D3. Although we
observed differential effects of the Vitamin D3 diet on DNp63a and VDR expression in chronically irradiated normal mouse
skin as well as UVB induced tumors, Vitamin D3 had little effect on PTEN expression in vivo. While low-grade papillomas in
mice exposed to UV and fed normal chow displayed increased levels of DNp63a, expression of both DNp63a and VDR was
reduced in invasive tumors. Interestingly, in mice fed high Vitamin D3 chow, elevated levels of DNp63a were observed in
both local and invasive tumors but not in normal skin suggesting that oral supplementation with Vitamin D3 may increase
the proliferative potential of skin tumors by increasing DNp63a levels.
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Introduction
1a,25-dihydroxyvitamin D3 (1,25(OH)2D3) has been investigat-
ed as an adjuvant to anti-cancer therapies. Upon binding to
Vitamin D Receptor (VDR), 1,25(OH)2D3 induces expression of
genes involved in apoptosis, differentiation and growth suppression
while down regulating expression of genes that are involved in
proliferation (reviewed in [1]). Keratinocytes synthesize 7-dehy-
drocholestrol, which is then converted to cholecalciferol by
exposure to ultraviolet B (UVB) light between 280–320 nm.
Intriguingly, these wavelengths of UVB are also the primary cause
of skin cancer. Unlike keratinocytes, no other cell types can
produce 1,25(OH)2D3 from 7-dehydrocholestrol and must rely on
the sequential transport of cholecalciferol to the liver and kidneys
to produce 25-hydroxyvitamin D3 and 1,25(OH)2D3, respectively.
Due to the relative instability of 1,25(OH)2D3, dietary supplements
commonly consist of cholecalciferol, also referred to as Vitamin D3
and rely on the conversion to 1,25(OH)2D3 by the liver and
kidneys.
Severe Vitamin D3 deficiency, measured by serum 25-hydro-
xyvitamin D levels, or deletion of the VDR gene is associated with
increased cancer risk [2,3]. Although topical application of
1,25(OH)2D3 reduced UVB-induced tumor burden in the SKH-
1 mouse model of squamous cell carcinoma [4], protective effects
of dietary Vitamin D3 against the development of skin cancer has
not been examined. This is an important study due to recent
reports highlighting the frequency of Vitamin D3 deficiency, and
its association with a myriad of disease states which has led to an
increase in Vitamin D3 supplement intake by the general public
[5].
On a cellular level, 1,25(OH)2D3, a downstream metabolite of
Vitamin D3, exerts its biological function by binding the
transcription factor VDR to control the expression of target
genes. We have previously demonstrated that p63 inhibits cell
invasion by directly regulating VDR and that both VDR and p63
are needed to inhibit cell invasion [6,7]. The transcription factor
p63 is essential for normal epidermal stratification and the
proliferative potential of the epithelial stem cells [8,9]. The
Tp63 gene can form several isoforms with contrasting functions,
using alternate promoters and 39 splicing. The TA isoforms
(TAp63a, TAp63b and TAp63c) have a full-length N-Terminal
transactivation domain, whereas the DN isoforms (DNp63a,
DNp63b and DNp63c) have a unique truncated transactivation
domain [10]. Our laboratory as well other researchers have
previously shown that DNp63a is the only detectable p63 isoform
expressed in the epidermis, specifically found in the proliferative
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basal layer [7,11–15]. DNp63a is overexpressed in squamous cell
carcinomas (SCC) and basal cell carcinomas (BCC) [11–13,16,17].
Contrary to its known roles in promoting epidermal differentia-
tion, VDR levels, much like DNp63a, are also elevated in BCC
and SCC [18,19]. Through its ability to induce VDR, DNp63a
could enhance 1,25(OH)2D3 signaling in non-melanoma skin
cancers.
In cell culture systems, 1,25(OH)2D3 seems to have paradoxical
pro-growth and pro-apoptotic functions. 1,25(OH)2D3 can prevent
apoptosis of UV-irradiated keratinocytes in culture through the
stabilization of DNp63a [20], or promote apoptosis through
increased expression of the tumor suppressor phosphatase and
tensin homolog deleted on chromosome 10 (PTEN) [21]. We have
demonstrated that DNp63a negatively regulates PTEN expression
and localization in keratinocytes to maintain normal growth rates.
Moreover, the ratio of DNp63a to PTEN expression is signifi-
cantly perturbed in human non-melanoma skin cancers [15].
In this study, we sought to delineate whether dietary Vitamin
D3 offered any protection against UVB induced tumor formation
and whether it preferentially induced expression of DNp63a,
VDR, or PTEN in vivo. We fed SKH-1 hairless mice chow
containing increasing concentrations of Vitamin D3 (cholecalcif-
erol) and chronically exposed them to UVB light modeling the
process of UV induced skin carcinogenesis in humans [14]. It has
been shown that development of skin tumors in the SKH-1
hairless mice resemble UV induced squamous cell carcinomas in
humans both morphologically as well at the molecular level [22].
Our results demonstrated that dietary Vitamin D3 offered no
protection from UVB induced tumor formation and in fact
increased tumor size at the highest dose tested. We observed
differential effects of Vitamin D3 diet on DNp63a and VDR but
not PTEN expression in chronically irradiated, but otherwise
normal skin and in UVB induced tumors.
Results
Effects of dietary Vitamin D3 on epidermal structure
To investigate the effect of increasing dietary Vitamin D3 on
epidermal biology we first measured the skin thickness in SKH-1
hairless mice exposed to chronic UVB irradiation. Dietary
Vitamin D3 alone did not alter the epidermal thickness of
unirradiated mice at any dose tested indicating that dietary
Vitamin D3 alone is insufficient to change epidermal proliferation.
Chronic UVB exposure significantly increased epidermal thickness
in all mice (Figure 1a &b). Interestingly, animals fed chow with
higher concentrations of dietary Vitamin D3 displayed increased
epidermal thickness in response to chronic UVB as compared to a
standard (3 IU) diet (Figure 1a & b). To assess changes in
proliferation, non-tumor dorsal skin sections were stained for
Ki67. As shown is Figure 1c regardless of Vitamin D3 diet there
was an increase in Ki67-positive cells in irradiated skin when
compared to un-irradiated skin from SKH-1 mice.
Epidermal thickness is mediated by changes in keratinocyte
proliferation and differentiation, both of which are regulated by
VDR and DNp63a. 1,25(OH)2D3 has also been shown to stabilize
both VDR and DNp63a [20,23]. To determine whether the
increase in epidermal thickness caused by increased dietary
Vitamin D3 was the result of enhanced VDR or DNp63a
expression, we stained skin tissues from UVB irradiated or control
SKH-1 mice fed varying doses of dietary Vitamin D3 for VDR,
DNp63a and their common transcriptional target PTEN. Since,
DNp63a is the only detectable p63 isoform found in the epidermis
we used a pan p63 antibody to detect DNp63a expression levels in
the skin tissues [7,11–15]. In unirradiated skin, increasing
concentrations of dietary Vitamin D3 had little effect on the
expression of VDR (Figure 2a, quantitated in lower panel). Lower
doses of dietary Vitamin D3 significantly increased VDR
expression in chronically UVB irradiated skin as compared to
unirradiated skin (Figure 2a). Interestingly, the increase in VDR
was not observed with higher concentrations of dietary Vitamin
D3 in irradiated skin and in fact VDR was significantly down
regulated in mice fed 1000 IU of Vitamin D3 diet compared to
irradiated mice fed the standard (3 IU) diet (Figure 2a).
Similarly, Vitamin D3 diet did not drastically alter DNp63a
expression in unirradiated skin (Figure 2b, quantitated in lower
panel). In mice fed a standard diet of Vitamin D3, chronic
exposure to UVB led to a significant increase in DNp63a
expression in the epidermis as compared to unirradiated mice
(Figure 2b). Contrary to previous reports in cultured keratinocytes
treated with calcitriol and exposed to acute UV radiation [20],
increasing concentrations of dietary Vitamin D3 led to a reduction
in the DNp63a expression in response to chronic UVB exposure
(Figure 2b).
Epidermal growth is also regulated by the tumor suppressor
PTEN, which inhibits cell proliferation [24,25]. Interestingly,
increasing concentrations of dietary Vitamin D3 (25 and 1000 IU)
significantly decreased PTEN expression in the epidermis of
unirradiated mice as compared to mice fed a standard 3 IU
Vitamin D3 diet (Figure 2c, quantitated in lower panel). Chronic
exposure to UVB significantly reduced the expression of PTEN in
the epidermis compared to unirradiated mice (Figure 2c).
Increasing dietary Vitamin D3 in UVB irradiated mice did not
further reduce PTEN levels.
Dietary Vitamin D3 trends toward increased UVB-induced
tumor development
We next wanted to determine whether dietary Vitamin D3
affects tumor formation, specifically tumor size and grade, in
response to chronic UVB exposure. Representative images of the
histology of the normal skin, papilloma, micro-invasive squamous
cell carcinoma (MiSCC) and SCC are shown in Figure S1, as
described previously [22]. Although increasing the amount of
Vitamin D3 in the diet trended toward an increase in the average
tumor area (Figure S2a) it was not statistically significant.
Moreover, mice fed higher doses of dietary Vitamin D3 displayed
a higher frequency of fully invasive squamous cell carcinomas
(SCC) as compared to mice fed a standard diet (Figure S2b), but
again this trend was not statistically significant. The increase in
SCC in mice fed 1000 IU VD3 did not alter the frequency of
papillomas, but rather correlated with a decrease in MiSCC as
compared to the mice fed standard diet, suggesting that higher
dietary Vitamin D3 may enhance tumor progression rather than
tumor initiation (Figure S2b).
Dietary Vitamin D3 differentially affects proteins involved
in epidermal maintenance during tumor progression
VDR has been shown to inhibit cell invasion [7], a hallmark of
tumor progression, and yet it has also been reported to be elevated
in BCC and SCC [18,19]. To determine whether there is a
correlation between VDR expression, Vitamin D3 diet, and tumor
grade, we determined VDR intensity in tumors of each grade from
mice fed increasing doses of dietary Vitamin D3. VDR expression
was significantly reduced in papillomas when compared to normal
epidermal tissue regardless of dietary levels of Vitamin D3
(Figure 3). VDR levels were also significantly reduced in MiSCC
and SCC as compared to normal epidermal tissue for all doses of
dietary Vitamin D3 tested. Interestingly, VDR expression was
Role of Vitamin D3 on Skin Cancer
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significantly reduced in SCCs formed in mice fed a 1000 IU
Vitamin D3 diet when compared to SCCs formed in mice fed a
standard diet. The lack of VDR, which has tumor suppressive
functions [3], in SCCs from mice fed 1000 IU Vitamin D3 diet
(Figure 3b) may explain the trend toward increased frequency of
SCC in animals on this diet (Figure S1b).
DNp63a, known to increase the proliferation of epidermal
keratinocytes, was significantly down regulated in normal epider-
Figure 1. Dietary Vitamin D3 does not significantly alter epidermal thickening induced in response to UVB irradiation. (a) Male SKH-1
mice were fed diets with increasing concentrations of Vitamin D3 and irradiated thrice weekly for 25 weeks with UVB. The epidermal thickness from
UV irradiated and unirradiated control mice are plotted. Error bars represent s.e.m. n = 15 UV exposed and n = 10 control unirradiated mice per
treatment condition. (b) Representative images of irradiated and unirradiated skin after Haemotoxylin and Eosin (H&E) staining. Photos from SKH-1
mice fed standard or increasing concentration of vitamin D3 chow were taken at a 10x magnification, scale bar = 20 mm. (c) Ki67 staining in normal
skin from irradiated and unirradiated skin obtained from mice fed diets with increasing concentration of Vitamin D3 as indicated. Ki67 images were
taken at a 20x magnification, scale bar = 20 mm.
doi:10.1371/journal.pone.0107052.g001
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mal tissue at all doses of dietary Vitamin D3 when compared to
mice fed a standard diet (Figure 4). Similar to VDR, DNp63a
expression was also increased in a dose dependent manner in
papillomas fed increasing doses of vitamin D3 chow. However,
unlike VDR, DNp63a expression levels were also increased in
both MiSCCs and SCCs (Figure 4b) with increasing doses of
Vitamin D3 diet. Interestingly, papillomas and MiSCC from mice
on the higher dietary Vitamin D3 (150 IU and 1000 IU) expressed
significantly more DNp63a than normal epidermal tissue from
mice of the same diet (Figure 5b). Loss of p63 has been associated
with increased cell invasion in urothelial and bladder cancers
[26,27]. Our results also demonstrated a significant reduction in
DNp63a expression in SCCs compared to MiSCC and normal
epidermal tissues from mice fed a standard diet (Figure 4b).
However, SCCs from mice fed increasing concentrations of
Vitamin D3 diet exhibited a dose dependent increase in DNp63a
expression levels suggesting that dietary Vitamin D3 enhances the
proliferative nature of SCC by preventing the down regulation of
DNp63a (Figure 4b).
To investigate if dietary Vitamin D3 leads to a reduction in the
expression of tumor suppressor PTEN, we measured the
expression of PTEN by immunofluorescence in normal skin and
tumors from UVB irradiated mice fed each of the Vitamin D3
diets. Increasing the concentration of Vitamin D3 in the diet did
not have consistent trends on the expression of PTEN between
tumor types (Figure 5). Consistent with previous reports [28],
PTEN was significantly reduced in UVB induced SCC compared
to normal skin independent of the Vitamin D3 diet (Figure 5),
suggesting that dietary Vitamin D3 does not increase the tumor
size or burden by augmenting UVB mediated degradation of
PTEN.
We have previously demonstrated that the ratio of DNp63a to
PTEN is critical for mediating keratinocyte proliferation and that
this ratio is significantly perturbed in human BCC and SCC [15].
Figure 2. Dietary Vitamin D3 differentially affects VDR, DNp63a and PTEN levels in response to UVB. Top panels show representative
images of (a) VDR, (b) DNp63a, or (c) PTEN staining in normal skin from irradiated and unirradiated skin obtained from mice fed diets with increasing
concentration of Vitamin D3 as indicated were taken at a 20x magnification, scale bar = 20 mm. Quantitation of (a) VDR, (b) DNp63a, or (c) PTEN
staining from three animals per treatment condition is plotted in the lower panels. Y-axis represents the mean fluorescent intensity, normalized to
background, in arbitrary units. Error bars represent standard error of mean. * = p#0.05 compared to unirradiated skin; # = p#0.05 compared to
respective unirradiated or irradiated skin from mice fed 3 IU Vitamin D3.
doi:10.1371/journal.pone.0107052.g002
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Figure 3. Effects of dietary Vitamin D3 on VDR expression during tumor progression. (a) Top panels show representative images taken at
a 20x magnification, scale bar = 20 mm of normal skin, benign papillomas, MiSCC and squamous cell carcinoma (SCC) from mice fed diets of
increasing concentrations of Vitamin D3 stained for VDR. (b) Quantitation of VDR levels from three animals per treatment condition is plotted. Y-axis
represents the mean fluorescent intensity, normalized to background, in arbitrary units. Error bars represent s.e.m. * = p#0.05 compared to normal
skin from the same diet; # = p#0.05 compared to tissue of same tumor grade from mice fed 3 IU Vitamin D3.
doi:10.1371/journal.pone.0107052.g003
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Figure 4. Effects of dietary vitamin D3 on DNp63a expression during tumor progression. (a) Top panels show representative images taken
at a 20x magnification, scale bar = 20 mm of normal skin, benign papillomas, MiSCC and SCC from mice fed diets of increasing concentrations of
Vitamin D3 stained for DNp63a. (b) Quantitation of DNp63a levels from three animals per treatment condition is plotted. Y-axis represents the mean
fluorescent intensity, normalized to background, in arbitrary units. Error bars represent s.e.m. * = p#0.05 compared to normal skin from the same diet;
# = p#0.05 compared to tissue of same tumor grade from mice fed 3 IU Vitamin D3.
doi:10.1371/journal.pone.0107052.g004
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Figure 5. Effects of dietary Vitamin D3 on PTEN expression during tumor progression. (a) Top panels show representative images taken at
a 20x magnification, scale bar = 20 mm of normal skin, benign papillomas, MiSCC and SCC from mice fed diets of increasing concentrations of Vitamin
D3 stained for PTEN. (b) Quantitation of PTEN levels from three animals per treatment condition is plotted. Y-axis represents the mean fluorescent
intensity, normalized to background, in arbitrary units. Error bars represent s.e.m. * = p#0.05 compared to normal skin from the same diet; # = p#
0.05 compared to tissue of same tumor grade from mice fed 3 IU Vitamin D3.
doi:10.1371/journal.pone.0107052.g005
Role of Vitamin D3 on Skin Cancer
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To determine if perturbation of the balance between DNp63a and
PTEN by dietary Vitamin D3 was contributing to the increase in
tumor size and SCC frequency, we calculated the ratio of DNp63a
to PTEN fluorescence intensity in normal skin and tumors from
UVB irradiated mice fed each of the Vitamin D3 diets. Mice fed a
diet of 1000 IU Vitamin D3 displayed consistently higher ratios of
DNp63a to PTEN, indicative of an increased proliferation
potential, in all tumor types as compared to normal skin (Figure 6).
Taken together, these studies suggest that increased dietary
Vitamin D3 may enhance UVB induced tumor formation and
progression, at least at supra-physiologic doses, by decreasing the
expression of VDR while increasing the DNp63a to PTEN ratio.
Discussion
1,25(OH)2D3 has been investigated as an adjuvant to anti-
cancer therapies because of its growth suppressive and pro-
differentiation properties. Although the association of Vitamin D3
consumption and serum 25-hydroxyvitamin D with the prevention
of a wide range of cancers has been widely studied [29], evidence
supporting the role of 1,25(OH)2D3 in protecting against skin
cancer is often conflicting [30–32]. In this study we demonstrate
that increased consumption of dietary Vitamin D3 in the SKH-1
mouse model of squamous cell carcinoma does not protect against
UVB-induced tumor formation (Figure S1). Moreover, supra-
physiologic levels (1000 IU) of dietary Vitamin D3 may actually
promote epidermal proliferation and tumor formation as evi-
denced by increased epidermal thickness and Ki67 staining
(Figure 1) and dose-dependent trends toward larger, more
aggressive tumor development (Figure S2).
The enhanced proliferation and tumor development in UVB
irradiated mice fed 1000 IU Vitamin D3 may be related to the
stabilization of the DNp63a (Figure 4), which is often overex-
pressed in human non-melanoma skin cancers [11–13,16,17].
Numerous models of acute UVB irradiation have demonstrated
that DNp63a must be down regulated to allow for apoptosis in the
epidermis [33–35]. It has been previously shown that ablation of
the basal layer cells of the interfollicular epidermis comprising of
mutant p53 and p63-positive cells led to a significant delay in the
onset of tumor formation in SKH-1 mice, suggesting that DNp63a
likely contributed to tumor formation [36]. Our studies show that,
unlike acute UVB exposure, DNp63a levels were significantly
higher in chronically UVB irradiated skin (Figure 2b) potentially
predisposing skin to tumor development. While we did not observe
an increase in DNp63a levels in response to increased dietary
Vitamin D3 in normal skin, we found that dietary Vitamin D3 was
able to limit the down regulation of DNp63a during tumor
progression (Figure 4). The sustained expression of DNp63a by
dietary Vitamin D3 could contribute to the proliferation and
expansion of UVB induced tumors.
Interestingly, the increase in DNp63a expression did not
correlate with increased expression of VDR, a direct transcrip-
tional target of p63 (Figures 3–4) [6]. This suggests that dietary
Vitamin D3, at least in the context of concomitant UVB
irradiation, may enhance the oncogenic properties of DNp63a
by increasing the ratio of DNp63a to PTEN (Figure 6), rather than
altering its tumor suppressive attributes, namely induction of
VDR.
Unlike previous studies conducted in 1,25(OH)2D3 deficient
rats, we did not observe an increase in epidermal VDR expression
in response to increased dietary Vitamin D3 (Figures 2a and 3)
[37]. This could be attributed to the inherent differences between
rats and SKH-1 mice and/or the differences in experimental
approach. In the studies conducted by Zineb et al., VDR
expression was measured in Wistar rats that were kept in the
dark, preventing the cutaneous production of 1,25(OH)2D3, and
fed a diet lacking Vitamin D3 to induce 1,25(OH)2D3 deficiency
before re-supplementation of dietary Vitamin D3 [37]. To better
mimic the environmental conditions experienced by humans, our
studies utilized a hairless mouse strain chronically exposed to UVB
without inducing 1,25(OH)2D3 deficiency prior to dietary Vitamin
D3 supplementation. It is important to note that while UVB is the
most common cause of non-melanoma skin cancers and its use as a
carcinogen is most physiologically relevant, the ability of
keratinocytes in the epidermis to generate 1,25(OH)2D3 in
response to UVB can confound the interpretation of how dietary
Vitamin D3 affects tumor formation.
Our results suggest that increased dietary Vitamin D3 may
enhance UVB induced tumor formation and progression (Figure
S2) by decreasing the expression of VDR in the epidermis
(Figure 3) while increasing DNp63a (Figure 4). The deleterious
effects of dietary Vitamin D3 observed in this study are consistent
with previous epidemiological studies showing that the risk for
non-melanoma skin cancers was positively correlated with
increasing serum 25-hydroxyvitamin D levels [30]. The U.S.
Preventive Services Task Force has reported that there is
insufficient data to support Vitamin D3 supplementation as a
cancer prevention method [38]. However, more efficient delivery
of 1,25(OH)2D3 to keratinocytes may also be critical to generating
protective rather than deleterious effects with regard to UVB
induced skin cancer.
A study by Dixon et al. demonstrated that topical application of
1,25(OH)2D3 led to a reduction in the development and size of
UV-induced tumors in the SKH-1 mouse model of squamous cell
carcinoma [4]. In contrast to our data obtained with dietary
Vitamin D3 (Figure S2), topical 1,25(OH)2D3 led to a reduction in
the incidence and progression of UV induced tumors [4]. Aside
from choice and route of delivery of vitamin D, there were
differences in the light source, UV exposure protocol, and sex of
mice used in our study compared to the topical calcitriol study.
Exposure of keratinocytes to UVB compared to solar simulated
light can alter signaling pathways in the skin [39,40]. Additionally,
our lab has demonstrated significant differences in the response to
UV light between the sexes [41] and also in response to treatment
[42]. Topical application of the active Vitamin D3 metabolite
Figure 6. Dietary Vitamin D3 alters the ratio of DNp63a to PTEN
during tumor progression. The average ratio of DNp63a fluores-
cence intensity to PTEN fluorescence intensity from normal skin, benign
papillomas, MiSCC, and SCC from mice fed diets of increasing
concentrations of Vitamin D3 as indicated is plotted. Error bars
represent standard error of mean from three animals per treatment
condition. * = p#0.05 compared to unirradiated skin.
doi:10.1371/journal.pone.0107052.g006
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1,25(OH)2D3 allows for direct activation of VDR and its
downstream effects in the skin. In contrast, the dietary Vitamin
D3 used in our study, must be absorbed by the intestines,
converted by liver and the kidney to 1,25(OH)2D3 and shuttled
back through the blood stream to the tumor site where it has to
reach critical levels to inhibit tumor progression.
Xenograft mice models of breast cancer have shown that dietary
vitamin D3 inhibited tumor formation in breast fat pad, metastases
to the lungs and reduced tumor size [43]. In this study they
observed that mice fed diets of up to 5000 IU/kg dietary vitamin
D3 had elevated 25(OH)D3 serum levels but no hypercalcemia as
evidenced by lack of increased calcium levels in serum. [43].
Moreover, mice fed 5000 IU/kg of dietary vitamin D3 showed a
reduction in the number and size of breast tumors. Differences in
the effects of dietary Vitamin D3 supplementation in the two
studies may be attributed to a 5 fold higher dose used in the breast
cancer xenograft model when compared to the 1000 IU/kg used
in our study as well as the tumor type being studied.
The current studies did not specifically examine the role of
interfollicular vs follicular cells and Vitamin D3 supplementation
in SCC formation. However, it has previously been shown that
while removal of the interfollicular epidermis by abrasion in CD-1
haired mice decreased the quantity of papilloma developed by
half, it did not delay or stop the development of papillomas [44].
Similarly, CO2 laser ablation of the interfollicular epidermis of
hairless mice did not delay or stop the development of tumors,
suggesting that a pool of cells deep in the hair follicle might be
responsible for the SCC development [45]. UV-induced ablation
of the epidermal basal layer in hairless mice further showed SCC
originated from the interfollicular epidermis which was being
repopulated from the hair follicle [36]. These studies suggest that
the decrease in hair follicles in our hairless mice, observed as they
age, did not impact tumor development in our study.
These studies demonstrate the complexity of Vitamin D3
supplementation and suggest the necessity for additional studies
to determine whether dietary Vitamin D3 or topical 1,25(OH)2D3
are viable therapeutic options since the application of
1,25(OH)2D3 to un-irradiated normal hairless mouse skin results
in dose and time dependent increases in mitosis and hyperplasia
[46]. Taken together these studies demonstrate that Vitamin D3
may have differing effects depending on the target organ and
mode of delivery. In the case of non-melanoma skin cancers it may
be detrimental at high levels because of its ability to stabilize




Male SKH-1 hairless mice were obtained from Charles River
Laboratories (Wilmington MA). Male SKH-1 mice were housed in
the vivarium at The Ohio State University according to the
requirements established by the American Association for
Accreditation of Laboratory Animal Care. The Ohio State
University Institutional Animal Care and Use Committee
approved all procedures before the initiation of any studies
(Protocol Number: 2010A00000083) and all efforts were made to
minimize suffering. Four week old animals were assigned to
different diets consisting of either standard chow with only 3 IU/
kg Vitamin D3 (8640 Teklad 22/5 Diet, Harlan Laboratories,
Madison, WI), or AIN93G diet modified to contain 25 IU/kg, 150
IU/kg, or 1000 IU/kg Vitamin D3 (Research Diets, New
Brunswick, NJ). The concentrations of Vitamin D3, in the form
of cholecalciferol, was based on the study by Fleet et al.
demonstrating that the dietary Vitamin D3 concentrations needed
for modeling human borderline deficiency (25–40 nmol/L)
average (50–60 nmol/L) and optimal (80–100 nmol/L) serum
25-hydroxyvitamin D concentrations as defined by NRC are 25–
50, 100, and 400 IU Vitamin D3/kg diet in growing rodents [47].
Twenty-five mice were assigned to each diet. Fifteen mice per diet
were dorsally exposed to 2240 J/m2 UVB, previously determined
to be to one minimal erythemic dose, 3 times weekly for a total of
25 weeks. UVB dose was calculated using a UVX radiometer and
UVB sensor (UVP, Upland, CA) and delivered using Philips TL
40W/12 RS SLV UVB broadband bulbs emitting 290–315 nm
UVB light (American Ultraviolet Company, Lebanon, as previ-
ously described [48]. Ten mice per diet served as age matched,
unirradiated controls. All mice were sacrificed by CO2 inhalation.
Quantitation of epidermal thickness
Epidermal morphology was analyzed using the Accustain
trichrome stain (Masson) kit according to manufacturer’s instruc-
tions (Sigma-Aldrich, St. Louis, MO). Epidermal thickness was
measured using ImageJ software at a magnification of 10x in all
tissue samples. Dorsal skin morphology was examined using H&E
staining and visualized/imaged using a Leica CTR 6000
Microscope (Leica Microsystems, Wetzlar, Germany) and Im-
agePro 6.2 software (Media Cybernetics, Bethesda, MD).
Tumor development and grade
Neoplastic lesions located on the dorsal skin measuring greater
than 1 mm in size were counted and measured (length 6width).
Tumors were measured using digital calipers throughout the
duration of the study. Tumor grade was determined from
hematoxyliln and eosin (H&E)-stained sections of tumors isolated
from UVB irradiated mice graded in a blinded manner by a board
certified veterinary pathologist as previously described [48].
Briefly, papillomas were exophytic tumors (tumors that grow
outward from the originating epithelium) that showed no invasion
of the stroma [22]. MiSCCs were distinguished by the depth of
penetration into the dermis [22]. Only tumors that invaded the
panniculus carnosus were classified as fully invasive SCCs [22].
Average tumor percentages were calculated using the total number
of graded tumors per treatment group.
Antibodies
PTEN, VDR, Ki67 and p63 antibodies were used to conduct
immunofluorescence staining. Pan p63 (clone: 4A4) used to detect
DNp63a, VDR (clone: 9A7) and PTEN (#9552) antibodies were
purchased from (Santa Cruz, CA, USA), (Thermo-Scientific,
Fremont, CA) and Cell Signaling (Danvers, MA, USA) respec-
tively. Ki67 (clone: SP6) antibody was purchased from abcam
(Cambridge, MA, USA).
Immunofluorescence
Tumors excised from dorsal skin as well as non-tumor dorsal
skin were formalin fixed, paraffin-embedded and stained for p63,
VDR and PTEN as previously described [7,15]. Ki67 staining was
preformed analogous to previously described staining of p63
[7,15]. For detection of VDR, paraffin was removed by four 10
minute washes in Histo-Clear (National Diagnostics, Atlanta, GA)
and rehydrated in graded series of alcohols with a final wash in
distilled water. After rehydration slides were incubated at 37uC for
20 minutes at 60uC in 2 N HCl. Slides were neutralized with 3
washes of 0.1 M sodium borate buffer (pH 8.5), followed by three
washes in PBS. Tissues were blocked for 3 hours with 5% normal
goat serum followed by overnight incubation with anti-VDR at
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4uC (clone 9–A7, Thermo-Scientific, Fremont, CA). Excess
primary antibody was removed with three consecutive washes in
PBS followed by incubation with AlexaFluor 568 goat anti-rat
antibody for 1 hour at room temperature. Excess secondary was
removed with three consecutive 5 min washes in PBS prior to
mounting with Vecta-Shield plus DAPI Mounting Media (Vector
Laboratories, Burlingame, CA). Cells were visualized and imaged
using a Leica CTR 6000 Microscope (Leica Microsystems,
Wetzlar, Germany) and ImagePro 6.2 software (Media Cybernet-
ics, Bethesda, MD). Mean fluorescence intensity for each tissue
sample was calculated using ImagePro 6.2 software after
normalization for background intensity. Multiple measurements
(at least 5), all of the same size, were taken of the epidermal tissue
for each tissue sample. Average mean fluorescence intensity was
calculated as previously described [15].
Statistics
Differences in mean fluorescence intensities were analyzed by
one-way ANOVA followed by pairwise multiple comparison
testing (Tukey test method, SigmaPlot 12, Dundas Software).
Supporting Information
Figure S1 SKH-1 mice skin following UVB induced
tumor development. SKH-1 mice fed chow with increasing
concentration of Vitamin D3 were irradiated thrice weekly for 25
weeks with UVB. Tumor excised from dorsal skin as well as non-
tumor (normal) dorsal skin were formalin fixed, paraffin embedded
and subjected to H&E staining. Representative images of a normal
skin, papilloma, MiSCC and SCC were taken at a 20x
magnification. Scale bar = 20 mm.
(PSD)
Figure S2 Effect of dietary Vitamin D3 on tumor
development. (a) The average tumor area per mouse is plotted
after 25 weeks of thrice weekly irradiation in mice fed diets with
increasing amounts of Vitamin D3. Error bars represent s.e.m. (b)
The distribution of premalignant papillomas and malignant
microinvasive squamous cell carcinomas (MiSCC) and malignant
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